NCT00348972View on ClinicalTrials.gov

Lantus in Prediabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

February 28, 2002

Conditions

HyperglycemiaDiabetes Mellitus

Interventions

DRUG

Lantus® (insulin glargine)

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00348972 - Lantus in Prediabetes | Biotech Hunter | Biotech Hunter